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Inadequate infection prevention and control (IPC) practices 
have highlighted concerns about the medical transmission 
of blood-borne and air-borne pathogens in South Africa. The 
National Department of Health (NDOH) and its partners have 
renewed efforts to minimise the risk of health care-associated 
transmissions.  The success of this endeavour depends on the 
involvement and dedication of doctors, nurses and all those 
who handle health risk waste. 
A key partner, Making Medical Injections Safer (MMIS), has 
implemented their project in 11 countries, including South 
Africa, since 2004.  The project is funded by the US President’s 
Emergency Plan for AIDS Relief (PEPFAR) and managed 
by John Snow, Inc. and its subcontractors, the Program 
for Appropriate Technology in Health, the Academy for 
Educational Development and the Manoff Group. 
The project promotes interventions aimed at preventing 
the transmission of health care-acquired infections and other 
blood-borne illnesses like HIV and AIDS by improving 
injection safety practices. These include safe management of 
sharps waste and promoting the rational use of injections. 
The project supports the strategies of the Safe Injection Global 
Network and the World Health Organization ensuring: the 
availability of appropriate injection-related commodities in 
medical settings; behaviour change and communications 
including training; to support the administration of safe 
and necessary injections; and appropriate health care waste 
management.  
MMIS supports Government efforts through the 
Departments (or Ministries) of Health and Environment, 
helping to implement a range of activities. These include the 
development and/or review of policies, the development 
of norms and standards, the introduction of their use, and 
monitoring their maintenance. The Departments or Ministries 
of Health also guide the implementation of training and 
behaviour change and communication activities, either for 
injection safety as a stand-alone programme area or, as in South 
Africa, within the context of IPC. Such activities have led to the 
development of the country’s first training manual on injection 
safety and the production of print, video, and computer-based 
educational materials for health care personnel. This training 
content is structured for different audiences, including top and 
middle managers of health care facilities, clinical staff, general 
assistants and waste handlers.  
The country has seen an increase in infant deaths associated 
with poor injection equipment use and practices, leading 
to outbreaks of Klebsiella as well as anecdotal reports of 
medical transmission of HIV.  These incidents have influenced 
the public and policy makers on IPC and overall safety, 
particularly in public health hospitals. 
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MMIS has also employed distance learning techniques 
to augment training capacity and capability.  A partnership 
between MMIS-South Africa, the NDOH and the MINDSET 
Health Channel has expanded the health channel to the whole 
country, adding connections to an additional 78 public health 
facilities between April and November 2006. The partnership 
also allowed the MINDSET Channel to launch its distance 
IPC learning curriculum, which is currently available in 300 
facilities in South Africa.
MMIS and the NDOH have collaborated through 
Government’s Khomanani Campaign towards the 
dissemination of critical injection safety-related messages 
and commodities in communities.  Using door-to-door visits, 
the aim is to create safer environments by ensuring the 
proper management of sharps waste for medical injections 
administered at home. 
Collaboration between MMIS and the NDOH (Quality 
Assurance, National Information System, and Government 
AIDS Action Plan Directorates) has enabled the key programme 
elements of injection safety to rapidly attain 100% district 
coverage. These have reached workers in health care facilities, 
learners at school, patients who take injectable medication 
at home, and middle managers at municipal, district and 
provincial levels. They are found within the National Infection 
Control Policy and Strategy framework which provides 
further policy context for the waste management and logistics 
activities. Interventions aim to build institutional capacity 
within the public health sector and ensure sustainability 
beyond MMIS lifecycle as a project (2009). 
Doctors protect themselves, patients and the community 
at large from the risk of disease transmission by observing 
standard precautions: washing hands, segregating waste, using 
protective equipment (gloves, masks, gowns, etc.), injecting 
safely, and keeping surfaces clean. It is paramount to uphold 
health care facilities as places of healing and not where people 
acquire infections. 
You are urged to join the NDOH and its partners and 
fight unsafe injections and poor infection control practices to 
improve services, patient safety, and the health of communities 
and the country. Please familiarise yourself with the National 
Infection Prevention and Control Policy and Strategy, and other 
relevant documents, that are available on the NDOH site or 
at their offices and on the MMIS site (www.doh.gov.za/www.
jsi.com). Please ensure that you are constantly updated by 
participating in IPC refresher courses.
South African TB Conference
Durban, 1 - 4 July 2008
The theme of the South African TB Conference is `Working as One’, and it is aimed at bringing together the 
public and private sectors, community members and civil society towards finding solutions to combat TB.
The three main tracks of the conference are:
•	 Track 1: Basic Science 
•	 Track 2: Clinical, epidemiological and operational research
•	 Track 3: Patient and civil society mobilisation and advocacy. 
Track 1 will focus on improving and expanding the understanding of the basic science that underpins 
advances in drugs, diagnostics and vaccines. Track 2 will cover the latest findings from clinical trials and 
research studies in the field of TB, while Track 3 will address community involvement and patient-driven 
partnerships in controlling TB.
For more information please visit the conference website: www.tbconference.co.za or contact  Ms 
Thabitha Tjatji of the Conference Secretariat on 012 460 8998 or thabithat@foundation.co.za 
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